Navigation Links
Rosetta Genomics Announces Plans to Recruit a New Chief Financial Officer
Date:6/25/2008

diagnostic and therapeutic products, focusing primarily on cancer and various women's health indications. The company expects its first microRNA-based diagnostic tests to be launched during 2008.

Forward-Looking Statement Disclaimer

Various statements in this release concerning Rosetta's future expectations, plans and prospects, including without limitation, statements relating to the role of microRNAs in human physiology and disease, the potential of microRNAs in the diagnosis and treatment of disease, and Rosetta's expectation to increase its senior management presence in the United States constitute forward-looking statements for the purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors, including risks related to: Rosetta's approach to discover and develop novel diagnostics and therapeutic products, which is unproven and may never lead to marketable products; Rosetta's ability to fund and the results of further pre-clinical and clinical trials; Rosetta's ability to obtain, maintain and protect the intellectual property utilized by Rosetta's products; Rosetta's ability to enforce its patents against infringers and to defend its patent portfolio against challenges from third parties; Rosetta's ability to obtain additional funding to support its business activities; Rosetta's dependence on third parties for development, manufacture, marketing, sales, and distribution of products; Rosetta's ability to successfully develop its product candidates, all of which are in early stages of development; Rosetta's ability to obtain regulatory approval for products; competition from others using technology similar to Rosetta's and others developing products for similar uses; Rosetta's dependence on collaborators; and Rosetta's short operating history; as well as those risks more fully d
'/>"/>

SOURCE Rosetta Genomics Ltd
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Rosetta Genomics Announces Three New Diagnostic Tests to Enter Development
2. Rosetta Genomics Executes Binding Term Sheet to Acquire U.S. CLIA-Certified Lab to Expedite Commercialization of Diagnostic Tests
3. /C O R R E C T I O N -- Rosetta Genomics Ltd/
4. Rosetta Genomics Reports First Quarter 2008 Financial Results
5. Rosetta Genomics Announces Conference Call and Webcast of First Quarter Financial Results
6. Rosetta Genomics Announces Expansion of its MicroRNA Intellectual Property Estate
7. Rosetta Genomics to Present Multiple Posters at the Annual American Association of Cancer Research (AACR) Conference
8. Accurate Identification of Tumor Origin Using MicroRNAs is Published by Rosetta Genomics Scientists and Collaborators in Nature Biotechnology
9. Rosetta Genomics Announces Allowance of Two Additional microRNA Patents
10. Rosetta Genomics Reports Fourth-Quarter and Full-Year 2007 Financial Results
11. Rosetta Genomics Establishes Medical Advisory Board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)DALLAS, Dec. 3 ACCESS PHARMACEUTICALS, INC. (OTC Bulletin Board: ACCP), today provided an update on its European commercial launch of MuGard, an FDA approved treatment for oral mucositis, a deb
(Date:12/3/2009)HOPKINTON, Mass., Dec. 3 Caliper Life Sciences, Inc. (Nasdaq: CALP ), a leading provider of tools and services for drug discovery and life sciences research, today introduced Living Image 4.0 softwa
(Date:12/2/2009)NEW YORK, Dec. 2 Reportlinker.com announces that a new market research report is available in its catalogue: ,, Carbondioxide Incubators - A Global Market Perspective ,, http://www.reportlinker.co
(Date:12/2/2009)CALGARY, Dec. 2 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. ("Oncolytics" or the "Company") (TSX:ONC; NASDAQ: ONCY ) announced today that in connection with its previously announced unit offering
Breaking Biology Technology:Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 2Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 3Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 4Caliper Life Sciences Launches Living Image(R) 4.0 Software 2Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 2Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 3Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 4Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 2Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 3Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 4
...t in Unresponsiveness to Patient Safety & Sati...if., March 24 The American Society of Anesthesiol...cal Association (AMA). Both publish monthly educat...ctively) and express an agenda for patient safety ...n primarily (and legitimately) as political organi...
... Mass.--New research findings at MIT could lead to...n is possible with today,s standard silicon chips,...ystems that can transmit data much faster. , The ...l called graphene, a form of pure carbon that was ...titutions have already used the one-atom-thick lay...
...EW, Calif., March 23 Alexza Pharmaceuticals, Inc....ate presentation will be webcast live during the 1...stry Conference on Thursday, April 2, 2009 at 3:00...ast from the Millennium Broadway Hotel & Confe...ive presentation via the Web, please go to the dir...
Other Biology Technology:American Society of Anesthesiologists Primary Agenda Displayed Says Dr. Barry Friedberg of Cosmetic Surgery Anesthesia 2MIT: New material could lead to faster chips 2MIT: New material could lead to faster chips 3Alexza's Corporate Presentation to be Webcast at the Future Leaders in the Biotech Industry Conference 2Alexza's Corporate Presentation to be Webcast at the Future Leaders in the Biotech Industry Conference 3
(Date:12/3/2009)Spanish researchers have measured CO2 levels for the past three years in the troposphere (lower atmosphere) over a sparsely inhabited rural area near Valladolid. The results, which are the first of th
(Date:12/3/2009)The 30-year record low in Antarctic snowmelt that occurred during the 2008-09 austral summer was likely due to concurrent strong positive phases for two main climate drivers, ENSO (El Nio - Southern O
(Date:12/2/2009)PHILADELPHIA New study results strengthen the evidence that people who smoke cigarettes over a long period of time have an increased risk for developing colorectal cancer, even after adjusting for ot
Breaking Biology News(10 mins):CO2 levels rising in troposphere over rural areas 2CCNY professor foresees rising Antarctic snowmelt 2Cigarette smoking increases colorectal cancer risk 2Explorers Bounty Contributing Charitable Bounty to Great Chefs of Los Angeles Event 60826 1Explorers Bounty Contributing Charitable Bounty to Great Chefs of Los Angeles Event 60826 2CEL SCI to Conduct First Clinical Study of Investigational LEAPS H1N1 Treatment for Hospitalized H1N1 Infected Patients at Johns Hopkins University Sc 60824 1CEL SCI to Conduct First Clinical Study of Investigational LEAPS H1N1 Treatment for Hospitalized H1N1 Infected Patients at Johns Hopkins University Sc 60824 2CEL SCI to Conduct First Clinical Study of Investigational LEAPS H1N1 Treatment for Hospitalized H1N1 Infected Patients at Johns Hopkins University Sc 60824 3NeurogesX Reports Third Quarter 2009 Results 14751 1NeurogesX Reports Third Quarter 2009 Results 14751 2NeurogesX Reports Third Quarter 2009 Results 14751 3NeurogesX Reports Third Quarter 2009 Results 14751 4NeurogesX Reports Third Quarter 2009 Results 14751 5NeurogesX Reports Third Quarter 2009 Results 14751 6NeurogesX Reports Third Quarter 2009 Results 14751 7NeurogesX Reports Third Quarter 2009 Results 14751 8NeurogesX Reports Third Quarter 2009 Results 14751 9NeurogesX Reports Third Quarter 2009 Results 14751 10
...esearchers are on the verge of unleashing the powe...s and therapies, as decades of research begins to ...ogy,s best kept secrets, but is now attracting fas...e pharmaceutical industry in the quest for novel d...entially overcoming limitations and side effects o...
...Do mothers purposely expose their offspring to the... because it is widely accepted that exposure to ma...e negative impacts on offspring following birth. T...o happen, evolutionary physiologists Oliver Love a...o the maternally-derived stress hormone corticoste...
...A 20-strong -team of cloud and climate experts fro... will today set off for Chile to investigate how m...c are affecting climate and weather all round the ... to reduce some of the largest errors currently in...ctions of future climate change. , These immens...
Other Biology News:European researchers harness unique properties of boron to develop new drugs and diagnostics 2European researchers harness unique properties of boron to develop new drugs and diagnostics 3Exposing chicks to maternal stress leads to long-term reproductive success 2British scientists go cloud-hopping in the Pacific to improve climate predictions 2
Taq DNA Polymerase from QIAGEN
Microfluidic Power Supply from Major Science
Rabbit Anti-Synapsin II Polyclonal Antibody, Unconjugated from Abcam
...erts cloned into M13/pUC-based plasmids, plasmids ...ters, or lambda gt10 and gt11 vectors. They are su...n water. The primers are functionally tested in DN...L™ II DNA Polymerase with an end-labeled prim...
Biology Products: